Your browser doesn't support javascript.
loading
Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.
Awwad, Hibah O; Durand, Cindy D; Gonzalez, Larry P; Tompkins, Paul; Zhang, Yong; Lerner, Megan R; Brackett, Daniel J; Sherry, David M; Awasthi, Vibhudutta; Standifer, Kelly M.
Afiliación
  • Awwad HO; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Oklahoma Center for Neuroscience, Oklahoma City, OK, USA. Electronic address: hawwad@ouhsc.edu.
  • Durand CD; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Gonzalez LP; Oklahoma Center for Neuroscience, Oklahoma City, OK, USA; Department of Psychiatry & Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Tompkins P; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Zhang Y; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Oklahoma Center for Neuroscience, Oklahoma City, OK, USA.
  • Lerner MR; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA; Oklahoma city VA Medical Center, Oklahoma City, OK 73117, USA.
  • Brackett DJ; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
  • Sherry DM; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Oklahoma Center for Neuroscience, Oklahoma City, OK, USA; Department of Cell Biology, College of Medicine, University of Oklahoma Health Sciences Center, USA.
  • Awasthi V; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Standifer KM; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Oklahoma Center for Neuroscience, Oklahoma City, OK, USA; Department of Cell Biology, College of Medicine, University of Oklahoma Health Sciences Center, USA.
Behav Brain Res ; 340: 183-194, 2018 03 15.
Article en En | MEDLINE | ID: mdl-27793733

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Traumatismos por Explosión / Encéfalo / Conmoción Encefálica / Hipoxia Encefálica / Cicloheptanos / Antagonistas de Narcóticos Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Behav Brain Res Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Traumatismos por Explosión / Encéfalo / Conmoción Encefálica / Hipoxia Encefálica / Cicloheptanos / Antagonistas de Narcóticos Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Behav Brain Res Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos